Mid-Year Oncology Review 2025: History Informs the Future

What are the promises and limitations of different therapeutic modalities in solid tumors? As we approach the mid-year point, we reflect on the advancements in oncology in recent years.

Ipsos Mid Year Oncology Review 2025 - History Informs the FutureIpsos explores challenges and opportunities in the development of emerging therapeutic modalities aimed at addressing solid tumors as well as prominent topics in the field including the dominance of small molecules as a time-tested and well-established modality that nonetheless continues to lead in FDA approval numbers each year; the potential of cancer vaccines to break through to the forefront owing to the opportunities created by mRNA-based neoantigens; and the journey of cell therapies as they start to penetrate solid tumor applications. 

In this white paper, supported by Ipsos’ survey of oncologists based in the US, as well as KOL interviews, we reveal 5 key themes in oncology and how past lessons inform the innovations of today.

Sign up to access the white paper

Related news

  • KEYS: Screen time
    Media Measurement Webinar

    [WEBINAR] KEYS: Screen time

    At our first KEYS webinar of the year we’ll be looking at what’s really happening on screens these days. What’s changing? What’s enduring? And how can businesses do better when it comes to engaging with people on their screens, in real time?
  • [Webinar] KEYS: What can we learn from what happened in 2025?
    Brand Image Webinar

    [Webinar] KEYS: What can we learn from what happened in 2025?

    In this final KEYS webinar of the year, we’ll be looking at the last 12 months through the rear-view mirror.
  • [Webinar] KEYS: THE MIDDLE CLASS: In Crisis?
    Society Webinar

    [Webinar] KEYS: THE MIDDLE CLASS: In Crisis?

    At our next KEYS webinar, we’ll be sharing on-the-ground perspectives as people give us their in-the-moment takes on how they see their lives - and their status in life - these days. Along the way we’ll hear about freedom (in the US), familismo (in Mexico) and understatedness (in the UK).